The Rotterdam Prostate Cancer Risk calculator (RPCRC, available as mobile phone app) has been extensively validated in the past years. Recently, a new version including MRI data has been released. The aim of our study was to analyze the performance of the MRI RPCRC app in a multicenter cohort of patients undergoing prostate biopsies.
Rotterdam mobile phone appincluding MRI data for the prediction of prostate cancer. A multicenter external validation / Cindolo, L., De Nunzio, C., Lombardo, R., Bertolo, R., Bove, P., Minervini, A., Sessa, F., Muto, G., Vittori, M., Bozzini, G., Castellan, P., Mugavero, F., Falsaperla, M., Schips, L., Celia, A., Bada, M., Porreca, A., Pastore, A., Al Salhi, Y., Giampaoli, M., et al.. - In: EUROPEAN UROLOGY OPEN SCIENCE. - ISSN 2666-1691. - 20:Supplemento 2(2020), pp. 46-46. (EAU 2020 Virtual Congress Online ) [10.1016/S2666-1683(20)35354-4].
Rotterdam mobile phone appincluding MRI data for the prediction of prostate cancer. A multicenter external validation
C. De Nunzio;R. Lombardo;A. Minervini;M. Falsaperla;A. Celia;A. Pastore;Y. Al Salhi;A. Antonelli;A. Tubaro
2020
Abstract
The Rotterdam Prostate Cancer Risk calculator (RPCRC, available as mobile phone app) has been extensively validated in the past years. Recently, a new version including MRI data has been released. The aim of our study was to analyze the performance of the MRI RPCRC app in a multicenter cohort of patients undergoing prostate biopsies.| File | Dimensione | Formato | |
|---|---|---|---|
|
Cindolo_Rotterdam-mobile-phone_2020.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
38.51 kB
Formato
Adobe PDF
|
38.51 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
